314 related articles for article (PubMed ID: 19252530)
21. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
[TBL] [Abstract][Full Text] [Related]
22. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.
Fu P; Bagai RK; Meyerson H; Kane D; Fox RM; Creger RJ; Cooper BW; Gerson SL; Laughlin MJ; Koc ON; Lazarus HM
Bone Marrow Transplant; 2006 Aug; 38(3):189-96. PubMed ID: 16850032
[TBL] [Abstract][Full Text] [Related]
23. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells.
Platzbecker U; Bornhäuser M; Zimmer K; Lerche L; Rutt C; Ehninger G; Hölig K
Transfusion; 2005 Jan; 45(1):11-5. PubMed ID: 15647012
[TBL] [Abstract][Full Text] [Related]
24. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
[TBL] [Abstract][Full Text] [Related]
25. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.
Selleri C; Montuori N; Ricci P; Visconte V; Baiano A; Carriero MV; Rotoli B; Rossi G; Ragno P
Cancer Res; 2006 Nov; 66(22):10885-90. PubMed ID: 17108125
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
[TBL] [Abstract][Full Text] [Related]
27. Clinical impact of a new automated system employed for peripheral blood stem cell collection.
Del Fante C; Perotti C; Viarengo G; Bellotti L; Parisi C; Marchesi A; Tinelli C; Salvaneschi L
J Clin Apher; 2006 Dec; 21(4):227-32. PubMed ID: 16847939
[TBL] [Abstract][Full Text] [Related]
28. Enumeration of bone marrow 'homing' haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation.
Spencer A; Jackson J; Baulch-Brown C
Bone Marrow Transplant; 2001 Dec; 28(11):1019-22. PubMed ID: 11781610
[TBL] [Abstract][Full Text] [Related]
29. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
Okano A; Ashihara E; Shimazaki C; Uchiyama H; Inaba T; Taniguchi K; Maekawa T; Taniwaki M
J Clin Apher; 2008; 23(6):171-7. PubMed ID: 18988229
[TBL] [Abstract][Full Text] [Related]
30. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies.
Szmigielska-Kaplon A; Szemraj J; Hamara K; Robak M; Wolska A; Pluta A; Czemerska M; Krawczynska A; Jamroziak K; Szmigielska K; Robak T; Wierzbowska A
Biol Blood Marrow Transplant; 2014 Jul; 20(7):986-91. PubMed ID: 24680978
[TBL] [Abstract][Full Text] [Related]
32. CD34+ cell responsiveness to stromal cell-derived factor-1alpha underlies rate of engraftment after peripheral blood stem cell transplantation.
Marquez-Curtis LA; Turner AR; Larratt LM; Letcher B; Lee SF; Janowska-Wieczorek A
Transfusion; 2009 Jan; 49(1):161-9. PubMed ID: 18954402
[TBL] [Abstract][Full Text] [Related]
33. Basal CD34(+) cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor.
de la Rubia J; Lorenzo JI; Torrabadella M; Marín P; Insunza A; Sanz MA
Haematologica; 2004 Dec; 89(12):1530-2. PubMed ID: 15590408
[TBL] [Abstract][Full Text] [Related]
34. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF).
Martino M; Callea I; Condemi A; Dattola A; Irrera G; Marcuccio D; Messina G; Pontari A; Pucci G; Console G; Lacopino P
J Clin Apher; 2006 Oct; 21(3):169-75. PubMed ID: 16532489
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings.
Wang TF; Wen SH; Chen RL; Lu CJ; Zheng YJ; Yang SH; Chu SC; Kao RH; Chen SH
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1305-11. PubMed ID: 18940686
[TBL] [Abstract][Full Text] [Related]
37. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization.
Jin F; Zhai Q; Qiu L; Meng H; Zou D; Wang Y; Li Q; Yu Z; Han J; Li Q; Zhou B
Bone Marrow Transplant; 2008 Nov; 42(9):581-8. PubMed ID: 18679363
[TBL] [Abstract][Full Text] [Related]
38. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.
Li B; Yang JL; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang S; Zhang CG
Cytotherapy; 2009; 11(3):362-71. PubMed ID: 19037766
[TBL] [Abstract][Full Text] [Related]
39. The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Cytotherapy; 2008; 10(5):507-17. PubMed ID: 18608354
[TBL] [Abstract][Full Text] [Related]
40. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
